基本信息
views: 46
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Robert Arnold Professor in the Department of Drug Discovery and Development and Director of Research Development & Support at the Harrison College of Pharmacy. In addition to his primary appoint he is an adjunct Professor in Pathobiology at Auburn University and Adjunct Professor in Small Animal Medicine and Surgery, University of Georgia, as well as Senior Scientist and Member of Experimental Therapeutics at the UAB O’Neal Comprehensive Cancer Center - an NIH Comprehensive Cancer Center. He obtained a Ph.D. (2004) in Pharmaceutical Sciences and completed postdoctoral training in cancer therapeutics and non-invasive imaging at the University at Buffalo and Roswell Park Cancer Institute. He has industrial (Wyeth-Ayers Research, now Pfizer) and academic experience in preclinical and translational development of therapies to human clinical studies. The focus of his research is the development and utilization of nanomedicines and alternate dosing schedules to improve the treatment of cancers. Specifically, he is interested in developing composite nanomedicines to improve drug delivery to primary tumors and metastatic disease and utilizing pharmacokinetic–pharmacodynamics (PK/PD) modeling and simulation to optimize drug dosing schedules. Furthermore, he is using a variety of contemporary molecular techniques to gain insights into how tumor microenvironment and alternate dosing schedules can alter the disposition and activity of drugs and nanomedicines. Dr. Arnold’s research is(has) been supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the National Cancer Institute (NCI) at the NIH, National Science Foundation (NSF), and a variety of private and public institutions. He has worked for and consults for a number of pharmaceutical companies and currently serves as an ad-hoc member of the Developmental Therapeutics (DT) NIH study section and serves on a number of special emphasis panels.
Research Interests
Papers共 126 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer and Metastasis Reviewsno. 2 (2024): 1-22
American journal of veterinary researchno. 9 (2023): 1-7
PLOS ONEno. 11 (2023): e0294280-e0294280
Molecular pharmaceuticsno. 8 (2023): 4236-4255
Cancer research communicationsno. 7 (2023): 1286-1311
Elizabeth W. Covington, Shaneese L. Jasper-Trotter,Robert D. Arnold, Raj Amin,Susan Egbert,Allison Chung
FUNDAMENTAL & CLINICAL PHARMACOLOGYno. 3 (2023): 588-595
Annabelle Vigneault,Natalie D Mylniczenko,Robert D Arnold, Shanese L Jasper-Trotter,Noémie Summa,Catherine Rousseau,Claire Vergneau-Grosset
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinariansno. 2 (2023): 401-405
Advanced healthcare materialsno. 32 (2023): e2301139-e2301139
International journal of molecular sciencesno. 10 (2023): 8490-8490
Taraswi Mitra Ghosh,Suman Mazumder,Joshua Davis,Jyoti Yadav,Ayuba Akinpelu,Ahmed Alnaim,Harish Kumar, Razan Waliagha,Allison E. Church Bird,Soroush Rais‐Bahrami, Richard M. Bird,Panagiotis Mistriotis,
openalex(2023)
Load More
Author Statistics
#Papers: 124
#Citation: 2433
H-Index: 27
G-Index: 47
Sociability: 6
Diversity: 3
Activity: 40
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn